SCHEMBL5250976

SCHEMBL5250976

COc1ccc(CNC(=O)CC(=O)O)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.69
ALDH1A1 P00352 3/20 0.62
TSHR P16473 1/20 0.60
GAA P10253 1/20 0.60
RAB9A P51151 3/20 0.59
PKM P14618 1/20 0.59
POLB P06746 2/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
ERCC1 P07992 1/20 0.56
ERCC4 Q92889 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
KDM4E B2RXH2 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5331532 0.87 ALDH1A1 (0.68) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL5902331 0.86 NPC1 (0.65) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL2797868 0.86 NPC1 (0.65) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL933858 0.84 NPC1 (0.67) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL27909130 0.84 ALDH1A1 (0.72) NPC1ALDH1A1TSHRGAAPKM
SCHEMBL14183972 0.84 NPC1 (0.62) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL27909118 0.84 ALDH1A1 (0.72) NPC1ALDH1A1TSHRPKMPOLB
SCHEMBL1695235 0.84 NPC1 (0.66) NPC1ALDH1A1TSHRGAARAB9A
SCHEMBL6530877 0.83 SMN1; SMN2 (0.69) NPC1ALDH1A1GAARAB9APOLB
SCHEMBL2795232 0.83 NPC1 (0.61) NPC1ALDH1A1TSHRGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045524-B2 Pleuromutilin derivatives with antimicrobial activity SMITHKLINE BEECHAM P.L.C. (GB) 2006-05-16 US claimed
US-20050143393-A1 Pleuromutilin derivatives with antimicrobial activity SMITHKLINE BEECHAM P.L.C. (GB) 2005-06-30 US claimed
EP-1355873-A1 PLEUROMUTILIN DERIVATIVES WITH ANTIMICROBIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2003-10-29 EP claimed
WO-2002038528-A1 PLEUROMUTILIN DERIVATIVES WITH ANTIMICROBIAL ACTIVITY SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-16 WO claimed
EP-1355873-B1 PLEUROMUTILIN DERIVATIVES WITH ANTIMICROBIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2007-07-25 EP disclosed
US-7045524-B2 Pleuromutilin derivatives with antimicrobial activity SMITHKLINE BEECHAM P.L.C. (GB) 2006-05-16 US disclosed
US-20050143393-A1 Pleuromutilin derivatives with antimicrobial activity SMITHKLINE BEECHAM P.L.C. (GB) 2005-06-30 US disclosed
EP-1355873-A1 PLEUROMUTILIN DERIVATIVES WITH ANTIMICROBIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2003-10-29 EP disclosed
WO-2002038528-A1 PLEUROMUTILIN DERIVATIVES WITH ANTIMICROBIAL ACTIVITY SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143393-A1 Pleuromutilin derivatives with antimicrobial activity PLEC, MLN, MRPL21 NPC1 4333/4885ALDH1A1 1950/4885TSHR 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.